Addressing Regulatory Query with Expert PK Reanalysis & Justification
Customer Requirement A pharmaceutical company specializing in generic drug development was in the process of seeking market approval for a generic product. During the regulatory review process, the benefit-risk department of the regulatory authority raised a query related to the statistical analysis of the submitted bioequivalence (BE) study data. The company required a comprehensive and […]
Addressing Regulatory Query with Expert PK Reanalysis & Justification Read More »